Back
Results - Announcements
Sales rise 3.92% to Rs 46.91 crore
Medicamen Biotech consolidated net profit declines 36.89% in the December 2025 quarter
14-Feb-2026, 07:56
Net profit of Medicamen Biotech declined 36.89% to Rs 2.19 crore in the quarter ended December 2025 as against Rs 3.47 crore during the previous quarter ended December 2024. Sales rose 3.92% to Rs 46.91 crore in the quarter ended December 2025 as against Rs 45.14 crore during the previous quarter ended December 2024.
Net profit of Medicamen Biotech declined 36.89% to Rs 2.19 crore in the quarter ended December 2025 as against Rs 3.47 crore during the previous quarter ended December 2024. Sales rose 3.92% to Rs 46.91 crore in the quarter ended December 2025 as against Rs 45.14 crore during the previous quarter ended December 2024.
| Particulars | Quarter Ended | ||
| Dec. 2025 | Dec. 2024 | % Var. | |
| Sales | 46.91 | 45.14 | 4 |
| OPM % | 9.34 | 14.86 | - |
| PBDT | 3.94 | 6.09 | -35 |
| PBT | 2.11 | 3.88 | -46 |
| NP | 2.19 | 3.47 | -37 |
Powered by Capital Market - Live News